Product
Al(OH)3
1 clinical trial
1 indication
Indication
InfluenzaClinical trial
A Randomized, Double-blind, Placebo-controlled, First-in-human Phase 1/2a Study to Evaluate Safety, Reactogenicity and Immunogenicity of a Universal Influenza (Uniflu) Vaccine With INFLUENZA G1 mHA in Healthy AdultsStatus: Active (not recruiting), Estimated PCD: 2024-08-24